Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:08 PM ET Form 4
Insider Selling Joby Aviation, Inc. JOBY

Joby Aviation Insider Sergey Novikov Sells $17.6K of Stock

Sergey Novikov sold 2,965 shares of Joby Aviation, Inc. at $5.95 a share, worth $17.6K in total on Oct 2, 2026. Shares held after the trade: 48,681 (-5.7%).

Value
$17.6K
Shares
2,965
Price
$5.95
Holding change
-5.7%
Trade date
Oct 2, 2026
4:08 PM ET 8-K
Business Update AbbVie Inc. ABBV

AbbVie Business Update

AbbVie provided a preliminary update for Q3 2026, noting that results will include $216 million in acquired IPR&D and milestones expense, which negatively impacts EPS by $0.11. Consequently, the company updated its full-year 2026 adjusted diluted EPS guidance to a range of $13.76 - $13.96 and its Q3 guidance to $3.73 - $3.77.

4:08 PM ET Form 4
Insider Selling Joby Aviation, Inc. JOBY

Joby Aviation Chief Policy Officer Gregory Bowles Sells $45.6K of Stock

Gregory Bowles, Chief Policy Officer, sold 7,663 shares of Joby Aviation, Inc. at $5.95 a share, worth $45.6K in total on Oct 2, 2026. Shares held after the trade: 199,006 (-3.7%).

Value
$45.6K
Shares
7,663
Price
$5.95
Role
Chief Policy Officer
Holding change
-3.7%
Trade date
Oct 2, 2026
4:08 PM ET Form 4
Insider Selling Joby Aviation, Inc. JOBY

Joby Aviation CFO Rodrigo Brumana Sells $15.5K of Stock

Rodrigo Brumana, CFO, sold 2,601 shares of Joby Aviation, Inc. at $5.95 a share, worth $15.5K in total on Oct 2, 2026. Shares held after the trade: 113,275 (-2.2%).

Value
$15.5K
Shares
2,601
Price
$5.95
Role
CFO
Holding change
-2.2%
Trade date
Oct 2, 2026
4:08 PM ET Form 4
Insider Selling Joby Aviation, Inc. JOBY

Joby Aviation Insider Kate DeHoff Sells $57K of Stock

Kate DeHoff sold 9,575 shares of Joby Aviation, Inc. at $5.95 a share, worth $57K in total on Oct 2, 2026. Shares held after the trade: 189,178 (-4.8%).

Value
$57K
Shares
9,575
Price
$5.95
Holding change
-4.8%
Trade date
Oct 2, 2026
4:08 PM ET Form 4
Insider Selling Joby Aviation, Inc. JOBY

Joby Aviation President of Operations Bonny W. Simi Sells $64.8K of Stock

Bonny W. Simi, President of Operations, sold 10,890 shares of Joby Aviation, Inc. at $5.95 a share, worth $64.8K in total on Oct 2, 2026. Shares held after the trade: 241,923 (-4.3%).

Value
$64.8K
Shares
10,890
Price
$5.95
Role
President of Operations
Holding change
-4.3%
Trade date
Oct 2, 2026
4:08 PM ET Form 4
Insider Selling Castle Biosciences Inc CSTL

Castle Biosciences COO Kristen M. Oelschlager Sells $149K of Stock

Kristen M. Oelschlager, COO, sold 4,153 shares of Castle Biosciences Inc at $35.75 to $36.38 a share (average $35.95) in 2 transactions, worth $149K in total on Oct 1, 2026. Shares held after the trade: 13,356 (-9.2%).

Value
$149K
Shares
4,153
Average price
$35.95
Role
COO
Holding change
-9.2%
Trade date
Oct 1, 2026
4:07 PM ET Form 4
Insider Selling Neptune Insurance Holdings Inc. NP

Neptune Insurance Holdings President & Chief Risk Officer Matthew Paul Duffy Sells $1.1M of Stock

Matthew Paul Duffy, President & Chief Risk Officer, sold 39,737 shares of Neptune Insurance Holdings Inc. at $27.65 to $28.48 a share (average $27.67) in 2 transactions, worth $1.1M in total on Oct 2, 2026. Shares held after the trade: 2,005,631 (-0.1%).

Value
$1.1M
Shares
39,737
Average price
$27.67
Role
President & Chief Risk Officer
Holding change
-0.1%
Trade date
Oct 2, 2026
4:07 PM ET 8-K
Stock Plan Amendment Silver Bow Mining Corp. SBMT

Silver Bow Mining Stock Plan Amendment

Silver Bow Mining Corp. granted 3,648 restricted stock units (RSUs) to Travis Naugle under the company's long-term incentive plan. The awards will vest upon a change in control, a sale of the majority of assets, or Mr. Naugle's departure from the Board.

4:07 PM ET 8-K
Business Update Lucid Group, Inc. LCID

Lucid Group Business Update

Lucid Group announced its Q3 2026 production and delivery totals, producing 2,954 vehicles and delivering 3,806 vehicles. The company is executing an operating reset to reduce inventory and align production with demand, targeting $1.4 billion in cash flow improvements for 2026. A formal earnings call to discuss full financial results is scheduled for November 9, 2026.

Term
Q3 2026
Earnings call
Oct 23, 2026, 5:30 PM ET
4:06 PM ET 8-K
Investor Presentation Serve Robotics Inc. SERV

Serve Robotics Investor Presentation

Serve Robotics Inc. updated its corporate investor presentation to include preliminary unaudited management estimates regarding its cost of revenue for the fiscal year ending December 31, 2026. The presentation highlights the company's commercial Level 4 autonomous robot fleets and its diversified revenue streams across delivery, healthcare, and advertising.

4:06 PM ET 8-K
Business Update Neostellar Capital Corp. NSLR

Neostellar Capital Business Update

Neostellar Capital Corp. provided a preliminary update for the third quarter ended September 30, 2026, estimating its Net Asset Value (NAV) to be between $12.25 and $12.75 per share. The company also detailed portfolio activity, including the exercise of warrants in Shogun Enterprises and exits from several positions including Learneo, Inc. and GrabAGun Digital Holdings.

Term
Q3 2026
4:06 PM ET Form 4
Insider Selling Iron Mountain Inc IRM

Iron Mountain EVP, Chief Commercial Officer Greg W. McIntosh Sells $554K of Stock

Greg W. McIntosh, EVP, Chief Commercial Officer, sold 5,000 shares of Iron Mountain Inc at $110.72 a share, worth $554K in total on Oct 1, 2026. Shares held after the trade: 70,634 (-6.6%).

Value
$554K
Shares
5,000
Price
$110.72
Role
EVP, Chief Commercial Officer
Holding change
-6.6%
Trade date
Oct 1, 2026
4:06 PM ET 8-K
Leadership Change OFA Group OFAL

OFA Group Leadership Change

OFA Group announced that Ernest Yeung resigned as Chief Financial Officer for personal reasons, effective September 30, 2026. The company appointed Eugene M. Johnston as the new CFO, effective October 1, 2026, under a two-year employment agreement providing a $150,000 base salary and an initial grant of 60,000 stock options.

Term
2 years
4:06 PM ET 8-K
Loan & Debt Aimei Health Technology Co., Ltd. AFJK

Aimei Health Technology Co Debt Financing Update with Aimei Investment Ltd

Aimei Health Technology Co., Ltd issued an unsecured promissory note for $34,330.96 to Aimei Investment Ltd to fund a deposit into its trust account. This payment extends the company's deadline to complete its initial business combination with United Hydrogen from October 6, 2026, to November 6, 2026.

Counterparty
Aimei Investment Ltd
Term
through consummation of business combination
4:06 PM ET 8-K
Other 8-K Filing Valuence Merger Corp. I VMCAF

Valuence Merger Corp. I Other 8-K Filing

Valuence Merger Corp. I has extended its deadline to complete an initial business combination from October 3, 2026, to November 3, 2026. This represents the sixth of ten available one-month extensions, and the company deposited $13,897.14 into its trust account to facilitate the move.

Term
1 month
4:06 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CFO Adam Laponis Sells $1.52M of Stock

Adam Laponis, CFO, sold 8,057 shares of Twist Bioscience Corp at $188.88 a share, worth $1.52M in total on Oct 2, 2026. Shares held after the trade: 100,576 (-7.4%).

Value
$1.52M
Shares
8,057
Price
$188.88
Role
CFO
Holding change
-7.4%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling Aflac Inc AFL

Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.32M of Stock

Japan Post Holdings Co. Ltd. sold 11,900 shares of Aflac Inc at $111.18 to $111.74 a share (average $111.18) in 2 transactions, worth $1.32M in total on Oct 1, 2026. Shares held after the trade: 50,433,390 (-0.0%).

Value
$1.32M
Shares
11,900
Average price
$111.18
Holding change
-0.0%
Trade date
Oct 1, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CEO Emily M. Leproust Sells $8.77M of Stock

Emily M. Leproust, CEO, sold 46,391 shares of Twist Bioscience Corp at $188.88 to $200.00 a share (average $189.04) in 2 transactions, worth $8.77M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 567,308 (-7.5%).

Value
$8.77M
Shares
46,391
Average price
$189.04
Role
CEO
Holding change
-7.5%
Trade date
Oct 1, 2026 to Oct 2, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience President and COO Patrick John Finn Sells $4.86M of Stock

Patrick John Finn, President and COO, sold 25,714 shares of Twist Bioscience Corp at $188.88 a share, worth $4.86M in total on Oct 2, 2026. Shares held after the trade: 185,088 (-12.2%).

Value
$4.86M
Shares
25,714
Price
$188.88
Role
President and COO
Holding change
-12.2%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience SVP of Human Resources Paula Green Sells $1.91M of Stock

Paula Green, SVP of Human Resources, sold 10,088 shares of Twist Bioscience Corp at $188.88 a share, worth $1.91M in total on Oct 2, 2026. Shares held after the trade: 106,632 (-8.6%).

Value
$1.91M
Shares
10,088
Price
$188.88
Role
SVP of Human Resources
Holding change
-8.6%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience Insider Dennis Cho Sells $1.8M of Stock

Dennis Cho sold 9,514 shares of Twist Bioscience Corp at $188.88 a share, worth $1.8M in total on Oct 2, 2026. Shares held after the trade: 63,789 (-13.0%).

Value
$1.8M
Shares
9,514
Price
$188.88
Holding change
-13.0%
Trade date
Oct 2, 2026
4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CAO Robert F. Werner Sells $280K of Stock

Robert F. Werner, CAO, sold 1,482 shares of Twist Bioscience Corp at $188.88 a share, worth $280K in total on Oct 2, 2026. Shares held after the trade: 42,917 (-3.3%).

Value
$280K
Shares
1,482
Price
$188.88
Role
CAO
Holding change
-3.3%
Trade date
Oct 2, 2026
4:04 PM ET Form 4
Insider Selling Nuscale Power Corp SMR

Nuscale Power CFO Robert Ramsey Hamady Sells $158K of Stock

Robert Ramsey Hamady, CFO, sold 20,000 shares of Nuscale Power Corp at $7.89 a share, worth $158K in total on Oct 1, 2026. Shares held after the trade: 144,235 (-12.2%).

Value
$158K
Shares
20,000
Price
$7.89
Role
CFO
Holding change
-12.2%
Trade date
Oct 1, 2026
4:03 PM ET Form 4
Insider Selling X4 Pharmaceuticals, Inc XFOR

X4 Pharmaceuticals CFO David Kirske Sells $33.7K of Stock

David Kirske, CFO, sold 11,767 shares of X4 Pharmaceuticals, Inc at $2.86 a share, worth $33.7K in total on Oct 1, 2026. Shares held after the trade: 155,983 (-7.0%).

Value
$33.7K
Shares
11,767
Price
$2.86
Role
CFO
Holding change
-7.0%
Trade date
Oct 1, 2026
4:02 PM ET 8-K
Regulatory Approval Endovia Health Sciences, Inc. EDVA

Endovia Health Sciences Regulatory Approval

Endovia Health Sciences announced that the FDA's Center for Veterinary Medicine determined its investigational drug CannEpil qualifies as a 'minor use' under the MUMS program for canine bone cancer pain. This designation allows the company to pursue a conditional approval pathway, which facilitates earlier market availability while additional effectiveness data is collected. The company is targeting a potential U.S. veterinary product launch in 2027.

Counterparty
Lupvindol BioSciences
4:02 PM ET Form 4
Insider Selling Semtech Corp SMTC

Semtech EVP and CFO Mark Lin Sells $173K of Stock

Mark Lin, EVP and CFO, sold 967 shares of Semtech Corp at $178.87 a share, worth $173K in total on Oct 1, 2026. Shares held after the trade: 35,999 (-2.6%).

Value
$173K
Shares
967
Price
$178.87
Role
EVP and CFO
Holding change
-2.6%
Trade date
Oct 1, 2026
4:02 PM ET 8-K
M&A Deal Peoples Bancorp Inc PEBO

Peoples Bancorp M&A Deal with Capital Bancorp, Inc.

Peoples Bancorp Inc. (PEBO) has entered into a definitive agreement to acquire Rockville, Maryland-based Capital Bancorp, Inc. Management described the transaction as a transformational combination that adds scale and a differentiated set of businesses to the Peoples franchise.

Counterparty
Capital Bancorp, Inc.
4:02 PM ET Form 4
Insider Selling Oklo Inc. OKLO

Oklo Co-Founder, COO Caroline Cochran Sells $4.38M of Stock

Caroline Cochran, Co-Founder, COO, sold 120,000 shares of Oklo Inc. at $36.19 to $37.07 a share (average $36.51) in 4 transactions, worth $4.38M in total on Oct 1, 2026. Shares held after the trade: 476,483 (-4.0%).

Value
$4.38M
Shares
120,000
Average price
$36.51
Role
Co-Founder, COO
Holding change
-4.0%
Trade date
Oct 1, 2026
4:02 PM ET Form 4
Insider Selling Oklo Inc. OKLO

Oklo Co-Founder, CEO Jacob DeWitte Sells $4.38M of Stock

Jacob DeWitte, Co-Founder, CEO, sold 120,000 shares of Oklo Inc. at $36.19 to $37.07 a share (average $36.51) in 4 transactions, worth $4.38M in total on Oct 1, 2026. Shares held after the trade: 509,479 (-3.8%).

Value
$4.38M
Shares
120,000
Average price
$36.51
Role
Co-Founder, CEO
Holding change
-3.8%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.